Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, JUBLIA® (efinaconazole).
Topical Solution, 10%, a treatment for onychomycosis, a fungal infection of the toenails, has received the American Podiatric Medical Association (APMA) Seal of Approval. The APMA Seal of Approval is granted to products that promote good foot health and are of significant value when used in a consistently applied program of daily foot care and regular professional treatment.
"We are pleased to receive this distinguished honor by the APMA, the leading professional organization for the more than 12,500 podiatrists in the United States," said Joseph C. Papa, chairman and CEO, Bausch Health. "The APMA Seal of Approval recognizes the demonstrated safety and efficacy profile of JUBLIA® and its continued use as a valuable treatment option for adults and children with toenail fungal infections. Since its initial approval to treat adults in 2014 and subsequent approval to treat pediatric patients six years of age and older in 2020, JUBLIA® has been available to help podiatrists and patients struggling with onychomycosis."
To earn the APMA Seal of Approval, products must undergo a rigorous scientific review by a committee of APMA podiatrists. The comprehensive review includes objective data from clinical and laboratory studies, patents and quality control, as well as details of intended use and product composition. Following a detailed review of the product by each committee member, a recommendation is sent to the APMA Board of Trustees, which either accepts or rejects the recommendation.
"Toenail fungus is extremely common, but it is an infection—and a highly contagious infection," said Jeffrey R. DeSantis, DPM, FACFAS, president of the American Podiatric Medical Association. "APMA is proud to bestow its Seal of Approval on products such as JUBLIA® that meet our physicians' highest standards for safety and effectiveness."
About Onychomycosis
Onychomycosis is a common condition, caused predominantly by various fungal organisms (fungi), and typically occurs under the toenail, though fingernails may also be affected. The condition typically begins as a small white or yellow spot beneath the nail, and causes nail discoloration, thickening and/or distortion and irregular surface changes. A severe case of nail fungus can be painful and may cause permanent nail damage.1
About APMA
The American Podiatric Medical Association (APMA) is the nation's leading professional organization for today's podiatrists. Doctors of Podiatric Medicine (DPMs) are qualified by their education, training, and experience to diagnose and treat conditions affecting the foot, ankle, and structures of the leg. APMA has 53 state component locations across the United States and its territories, with a membership of more than 12,500 podiatrists. All practicing APMA members are licensed by the state in which they practice podiatric medicine. For more information, visit www.apma.org.
About Ortho Dermatologics
Ortho Dermatologics is one of the largest prescription and aesthetic dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. The Ortho Dermatologics portfolio also includes several leading medical device systems for aesthetic applications, such as skin tightening and resurfacing, laser hair removal and preventative therapeutic skin care treatments. More information can be found at www.ortho-dermatologics.com.
For more information please visit www.bauschhealth.com
